comparemela.com

Latest Breaking News On - பார் மருந்துகள் இன்க் - Page 1 : comparemela.com

Woman allegedly requires hysterectomy to remove defective intrauterine device

Rosenstengel EAST ST. LOUIS A woman is suing the manufacturers of Paragard, alleging she had to undergo a hysterectomy to fully remove the intrauterine device.  Georgia Motter filed a complaint May 14 in the U.S. District Court for the Southern District of Illinois East St. Louis Division against Teva Pharmaceuticals USA Inc., Teva Women s Health LLC, individually and as successor in interest to Teva Women s Health Inc., Duramed Pharmaceuticals Inc., a division of Barr Pharmaceuticals Inc.,  doing business as Teva Women s Health Inc., The Coopersurgical Inc., and others, alleging negligence, strict liability design defect and manufacturing defect, failure to warn, fraud and other claims. 

Illinois
United-states
Ohio
Cleveland
Bruce-taubman
Teva-women-health
Teva-women-health-inc
Coopersurgical-inc
Us-district-court
Barr-pharmaceuticals-inc
Duramed-pharmaceuticals-inc
Teva-pharmaceuticals-united-states-inc

BioSpace Movers & Shakers, May 21

Published: May 21, 2021 By Alex Keown Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.  AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Prior to bluebird bio, Hanrahan held positions of increasing responsibility at Genzyme Corp. where she worked across the oncology, multiple sclerosis and rare disease therapeutic areas. Earlier in her career, Hanrahan worked at Boston Scientific Corporation.

Colorado
United-states
Italy
Boston
Massachusetts
Milan
Lombardia
Oregon
Netherlands
America
Dutch
Stephen-basso

Miller Law LLC and Safirstein Metcalf LLP Announce Notice of Certified Litigation Class Action in In re Namenda Indirect Purchaser Antitrust Litigation

Miller Law LLC and Safirstein Metcalf LLP Announce Notice of Certified Litigation Class Action in In re Namenda Indirect Purchaser Antitrust Litigation News provided by Share this article UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK NOTICE OF CERTIFIED LITIGATION CLASS ACTION PLEASE READ THIS ENTIRE NOTICE CAREFULLY. A UNITED STATES FEDERAL COURT AUTHORIZED THIS NOTICE. YOUR RIGHTS MAY BE AFFECTED BY THE PROCEEDINGS IN THIS ACTION. THIS NOTICE ADVISES YOU OF YOUR RIGHTS AND OPTIONS WITH RESPECT TO THIS ACTION. This class certification Notice provides class members with a deadline of May 28, 2021, to exclude themselves from the Third-Party Payor ( TPP ) Class.

Alabama
United-states
Nevada
Vermont
Minnesota
California
New-mexico
West-virginia
Arizona
India
Massachusetts
Iowa

U.S. District Court for the Eastern District of Pennsylvania: Actions Taken on Feb. 25

C R Bard Inc.: Remark: Transferring Case To The Eastern District Of Pennsylvania Via Electronic Transfer. This Is A Text Entry Only. There Is No Pdf Document Associated With This Entry. (map) [transferred From Arizona On 2/25/2021.] Weekly Newsletter Sign up × By signing up you agree to receive email newsletters or alerts from Pennsylvania Record. You can unsubscribe at any time. Protected by Google ReCAPTCHA. Case Transferred In From District Of Arizona; Case Number 2:17-cv-03568. Original File Certified Copy Of Transfer Order And Docket Sheet Received. Case number 2:21-cv-00874-MAK was filed in the U.S. District Court for the Eastern District of Pennsylvania.

Arizona
United-states
Pennsylvania
New-jersey
Sarah-burke
Carolyn-cato
Priscilla-james
Theodore-david-kanas
Johnf-breig
Betsie-deane
William-fitzpatrick
Krishna-harohalli

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.